Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 15,035 followers.

#lifechangingpapers http://t.co/HDxzZwyljx First immunotherapy paper, read in journal club. Authors became mentors. https://t.co/rUQmpq8TmB

#lifechangingpapers http://t.co/HDxzZwyljx First immunotherapy paper, read in journal club. Authors became mentors. https://t.co/rUQmpq8TmB

#lifechangingpapers http://t.co/HDxzZwyljx First immunotherapy paper, read in journal club. Authors became mentors. https://t.co/rUQmpq8TmB

Earlier = better for immune therapy. Does not matter for cytotoxic therapy. http://t.co/LMzDVCsLgp http://t.co/jfdIB89KAM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.